New study aims to safely treat malaria in patients with enzyme deficiency
Disease control
Recruiting now
This study looks at how safe and effective primaquine is for treating vivax malaria in people with intermediate or low G6PD enzyme levels. Participants with intermediate G6PD activity will receive a high daily dose for 7 days, while those with severe deficiency will get a weekly …
Phase: PHASE4 • Sponsor: Menzies School of Health Research • Aim: Disease control
Last updated May 12, 2026 13:40 UTC